Sprinklr

CXM · NYSE

$6.45+$0.33 (+5.39%)TodayMarket closed ·
Prev close $6.12

CXM analyst rating

HoldConsensus of 5 analysts over the last 12 months. 40% rate it a buy.
  • Strong buy0
  • Buy2
  • Hold3
  • Underperform0
  • Sell0

12-month price target · 9 analysts

Average $8.61 (+33.4% upside)

Low
$6.06
Now
$6.45
High
$12.60

Upgrades and downgrades

The latest rating actions, newest first

CXM analyst upgrades, downgrades and rating actions
FirmDateActionRating
CitizensSep 21, 2026MaintainsMarket Outperform
DA DavidsonSep 3, 2026MaintainsNeutral
CitigroupSep 3, 2026MaintainsNeutral
Morgan StanleySep 3, 2026MaintainsEqual-Weight
RosenblattSep 3, 2026MaintainsBuy
CitigroupJun 4, 2026MaintainsNeutral
DA DavidsonJun 4, 2026MaintainsNeutral
RosenblattJun 4, 2026MaintainsBuy
DA DavidsonApr 17, 2026MaintainsNeutral
Morgan StanleyMar 16, 2026MaintainsEqual-Weight

The case for and against

Updated Oct 14, 2026

Bull case

Sprinklr is benefiting from improving demand and broadening platform adoption, with net new ARR inflecting positive to $54.0M, revenue reaching $220.5M, and 59% of customers now using 4+ products versus 51% a year ago, signaling stronger cross-sell and deeper consolidation across its unified AI platform. Retention and backlog trends also strengthened, as net revenue retention rose to 114%, gross retention hit a company record, and RPO increased 36% year over year to $1.35B, supporting greater visibility into future recurring revenue. Operational discipline adds to the bullish case, with non-GAAP operating margin improving meaningfully and free cash flow guidance of $150M supporting continued share repurchases and strategic M&A that can extend its competitive moat.

Bear case

Sprinklr is facing a fundamental slowdown as management lowered FY27 total revenue guidance to $866.5M-$886.5M and Non-GAAP operating income to $140M at the midpoint, reflecting macro headwinds, deal delays, and weaker professional services demand. The company’s key near-term risk is whether net new ARR can re-accelerate after a 4% Y/Y deceleration in Q4 FY26, because further deterioration would imply structural demand weakness and downside to the FY27E ARR estimate of $989M. Its outlook is also constrained by intense CXM competition, evolving data-privacy and cybersecurity risks, and dependence on external data channels, while margin improvement remains limited by incremental AI investment and only 3% subscription growth at the midpoint.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.